This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

CRA Insights

CRA Insights: Life Sciences: November 2014

November 13, 2014

This newsletter highlights recent thinking and announcements from members of the Life Sciences Practice.

Download

Related capabilities

Life Sciences

Share

Life Sciences
CRA Insights

MFN is rewriting the launch planning playbook: Commercial and market access strategies must integrate to succeed

MFN-related uncertainty is reshaping pharmaceutical launch planning by making pricing, sequencing, and forecasting decisions more interconnected and...
Life Sciences
Reports

Ending the HIV epidemic: Ensuring equitable access to innovative HIV treatment and care

While advances in prevention, testing, and treatment have transformed outcomes for many people living with or at risk of HIV, significant inequities continue...

Explore our thinking

Damages & Quantum
Sponsorship & Speaking Engagement

September 15-16, 2026

Boston, MA

Pharma & Biotech Patent Litigation Summit North America 2026

CRA is a proud sponsor of the conference. Greg Bell speaks during the session titled “Damages in Pharma & Biotech Litigation: What Courts are Accepting...